Lumos Pharma Future Growth
Future criteria checks 0/6
Lumos Pharma's revenue and earnings are forecast to decline at 1.8% and 11.6% per annum respectively while EPS is expected to grow by 41.3% per annum.
Key information
-11.6%
Earnings growth rate
41.3%
EPS growth rate
| Biotechs earnings growth | 28.4% |
| Revenue growth rate | -1.8% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 08 Nov 2024 |
Recent future growth updates
Recent updates
We're A Little Worried About Lumos Pharma's (NASDAQ:LUMO) Cash Burn Rate
May 23
We're Keeping An Eye On Lumos Pharma's (NASDAQ:LUMO) Cash Burn Rate
Aug 25Is Lumos Pharma (NASDAQ:LUMO) In A Good Position To Deliver On Growth Plans?
Mar 13Lumos Pharma announces new buyback program
Aug 16Here's Why We're Not Too Worried About Lumos Pharma's (NASDAQ:LUMO) Cash Burn Situation
Mar 22Companies Like Lumos Pharma (NASDAQ:LUMO) Are In A Position To Invest In Growth
Nov 04What Kind Of Investors Own Most Of Lumos Pharma, Inc. (NASDAQ:LUMO)?
Dec 09Lumos Pharma (LUMO) Investor Presentation - Slideshow
Nov 17Lumos Pharma, Inc. 2020 Q3 - Results - Earnings Call Presentation
Nov 11Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1 | -51 | N/A | -49 | 3 |
| 12/31/2025 | 1 | -43 | N/A | -41 | 4 |
| 12/31/2024 | 6 | -30 | N/A | -34 | 4 |
| 9/30/2024 | 2 | -35 | -32 | -32 | N/A |
| 6/30/2024 | 1 | -36 | -34 | -34 | N/A |
| 3/31/2024 | 2 | -37 | -35 | -35 | N/A |
| 12/31/2023 | 2 | -34 | -31 | -31 | N/A |
| 9/30/2023 | 2 | -33 | -30 | -30 | N/A |
| 6/30/2023 | 2 | -32 | -27 | -27 | N/A |
| 3/31/2023 | 2 | -31 | -28 | -28 | N/A |
| 12/31/2022 | 2 | -31 | -27 | -27 | N/A |
| 9/30/2022 | 1 | -28 | -27 | -27 | N/A |
| 6/30/2022 | 1 | -29 | -28 | -28 | N/A |
| 3/31/2022 | 0 | -30 | -27 | -27 | N/A |
| 12/31/2021 | 0 | -30 | -30 | -30 | N/A |
| 9/30/2021 | 0 | -27 | -31 | -31 | N/A |
| 6/30/2021 | 0 | -18 | -23 | -23 | N/A |
| 3/31/2021 | 0 | -15 | -30 | -30 | N/A |
| 12/31/2020 | 0 | -6 | -23 | -23 | N/A |
| 9/30/2020 | 0 | -7 | -19 | -19 | N/A |
| 6/30/2020 | 0 | -12 | -21 | -21 | N/A |
| 3/31/2020 | 0 | -10 | -10 | -10 | N/A |
| 12/31/2019 | N/A | -13 | -9 | -9 | N/A |
| 9/30/2019 | N/A | -11 | -8 | -8 | N/A |
| 12/31/2018 | N/A | -11 | -11 | -7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LUMO is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: LUMO is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: LUMO is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: LUMO's revenue is expected to decline over the next 3 years (-1.8% per year).
High Growth Revenue: LUMO's revenue is forecast to decline over the next 3 years (-1.8% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if LUMO's Return on Equity is forecast to be high in 3 years time